NEW YORK – Proteomics firm Somalogic said on Wednesday that it has closed a $121 million Series A funding round that it plans to use to expand and further commercialize its SomaScan platform and SomaSignal proteomic tests.
NEW YORK – Proteomics firm Somalogic said on Wednesday that it has closed a $121 million Series A funding round that it plans to use to expand and further commercialize its SomaScan platform and SomaSignal proteomic tests.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.